Your trusted source for investing success
Bellicum Pharmaceuticals (NASDAQ:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock at a price to the public of $7.50 per share. The aggregate
Aeglea BioTherapeutics (Nasdaq:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer, today announced that it has commenced an underwritten public offering of 4,500,000 shares of its common stock. The offering is subject to market conditions, and there can be
Apellis Pharmaceuticals (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, today announced that it has commenced an underwritten public offering of 5,000,000 shares of its common stock. All of the shares are being offered by
Bellicum Pharmaceuticals (NASDAQ:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that it has commenced an underwritten public offering of 7,000,000 shares of its common stock. All shares of common stock to be sold in the offering
Lomiko Metals Inc. (TSXV:LMR, OTCQX:LMRMF, FSE:DH8B) (“Lomiko” or “the Company”), CEO A. Paul Gill joins Uptick Newswire’s Everett Jolly.
By Bala Yogesh
Which NASDAQ tech stocks gained the most last week? CYREN, Meet Group, RealNetworks, Simulation Plus and eGain were the top gainers.
Novelion Therapeutics, EyePoint Pharmaceuticals, CytRx, Viking Therapeutics and AVEO Pharmaceuticals were last week’s top gainers.
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the past trading week.
In case you missed it, here is this week’s cannabis big news roundup.
In case you missed it, here is this week’s big news roundup in the Life Science sector.
By Bala Yogesh
Sphere 3D Corp (NASDAQ:ANY) announced the pricing of underwritten public offering of 3.3 million shares of its common stock and warrants to purchase up to an aggregate of 990,000 shares at an aggregate price of $0.70 per common share and accompanying warrant. Sphere 3D is a company delivery virtualization and data
EyeGate Pharmaceuticals (NASDAQ:EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for treating diseases and disorders of the eye, announced today the pricing of a public offering of an aggregate of 35,156,250 shares of common stock (or common stock equivalents) and warrants to purchase an aggregate of 35,156,250
PolarityTE (Nasdaq:COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products for the fields of medicine, biomedical engineering and material sciences, today announced that it has commenced an underwritten public offering of shares of its
Novavax (Nasdaq:NVAX), a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases, today announced that it intends to offer to sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. As part of this offering Novavax intends to grant the
A company getting approval to list to the NASDAQ means a more international reach for Canadian companies listing on the TSX and TSXV.
Helius Medical Technologies (TSX:HSM) (NASDAQ:HSDT) announced the pricing of an underwritten public offering of 2,141,900 shares of its Class A common stock and warrants to purchase 2,141,900 shares of its Class A common stock at a public offering price of US$7.47 per share and accompanying warrant, before underwriting discounts and commissions.
High Hampton Holdings Corp (CSE:HC) today announced that it has retained Marc J. Ross, Esq., of Sichenzia Ross Ference Kesner LLP, as the Company’s U.S. Cannabis Legal Counsel to advise and consult on all cannabis-related legal matters as applicable to the Company’s business model, strategy and p
By Bala Yogesh
Carbon Black, a cybersecurity innovator and a leading provider of next-generation endpoint security announced it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock.
As quoted in the press release:
The
Inspire Medical Systems a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public
By Bala Yogesh
Which NASDAQ tech stocks gained the most last week? Zix, Sify, Simulation Plus, eGain and Cyren were the top gainers.
